MINNEAPOLIS--(BUSINESS WIRE)--Target Corporation (NYSE: TGT) today reported first quarter 2016 comparable sales growth of 1.2 percent, and adjusted earnings per share from continuing operations1 (Adjusted EPS) of $1.29, up 16.5 percent from $1.10 in 2015. First quarter GAAP earnings per share (EPS) from continuing operations were $1.02, compared with $1.01 in first quarter 2015. First quarter 2016 GAAP EPS from continuing operations reflects $261 million of pre-tax early debt retirement losses, costs related to the sale of the pharmacy and clinic businesses to CVS Health and the resolution of income tax matters. The attached tables provide a reconciliation of non-GAAP to GAAP measures for first quarter 2016. All earnings per share figures refer to diluted EPS.
1 Adjusted EPS, a non-GAAP financial measure, excludes losses on the early retirement of debt, charges and expenses related to the sale of the pharmacy and clinic businesses to CVS, and the impact of certain matters not related to the Company’s single segment, such as discontinued operations, data breach expenses, restructuring costs, and certain other expenses that are discretely managed. See the “Discontinued Operations” and “Miscellaneous” sections of this release, as well as the tables of this release, for additional information about the items that have been excluded from Adjusted EPS. |
“We are pleased with our first quarter financial results, which demonstrate the effectiveness of our strategy in an increasingly volatile consumer environment,” said Brian Cornell, chairman and CEO of Target. “First quarter comparable sales in Signature Categories grew more than three times the Company average, digital comparable sales grew 23 percent, and strong execution by our team delivered stronger-than-expected growth in Adjusted EPS. With an outstanding team, a resilient business model and a strong balance sheet, we plan to successfully implement our long-term strategy, even in the face of a challenging short-term consumer landscape.”
Fiscal 2016 Earnings Guidance
While the Company’s view of second quarter results has been tempered by the recent slowdown in consumer trends, Target currently believes full-year adjusted EPS within its prior guidance range is achievable.
In second quarter 2016, Target expects comparable sales of flat to down two percent, and Adjusted EPS of $1.00 to $1.20. Second quarter GAAP EPS from continuing operations will include approximately $0.17 of expense related to early debt retirement losses, and also may include the impact of certain additional discrete items which will be excluded in calculating Adjusted EPS. In the past, these items have included data breach expenses, restructuring costs and certain other items that are discretely managed. Beyond losses related to the early debt retirement, Target is not currently aware of any other material discrete items.
Segment Results
First quarter 2016 sales decreased 5.4 percent to $16.2 billion from $17.1 billion last year, as a 1.2 percent increase in comparable sales was more than offset by the impact of the sale of the pharmacy and clinic businesses. Comparable digital channel sales grew 23 percent and contributed 0.6 percentage points to comparable sales growth. Segment earnings before interest expense and income taxes (EBIT) were $1,323 million in first quarter 2016, an increase of 4.9 percent from $1,261 million in 2015.
First quarter EBITDA and EBIT margin rates were 11.5 percent and 8.2 percent, respectively, compared with 10.5 percent and 7.4 percent, respectively, in 2015. First quarter gross margin rate was 30.9 percent, compared with 30.4 percent in 2015, reflecting the benefit of the sale of the Company’s pharmacy and clinic businesses, combined with the benefit of the Company’s cost savings initiatives, partially offset by investments in promotions. First quarter SG&A expense rate was 19.4 percent in 2016, compared with 19.9 percent in 2015, reflecting the benefit of the sale of the Company’s pharmacy and clinic businesses along with continued expense discipline across the organization.
Interest Expense and Taxes from Continuing Operations
The Company’s first quarter 2016 net interest expense was $415 million, compared with $155 million last year, driven by a $261 million charge related to the early retirement of debt. First quarter 2016 effective income tax rate from continuing operations was 31.6 percent, compared with 34.8 percent last year. The decrease was primarily due to the adoption of new accounting standards for employee share-based payments, which reduced the effective tax rate by approximately 1.9 percentage points, and losses related to the early retirement of debt.
Capital Returned to Shareholders
In first quarter 2016, the Company repurchased 11.4 million shares of common stock at an average price of $78.37, for a total investment of $893 million. The Company also paid dividends of $336 million. In total, the Company returned $1,229 million to shareholders in first quarter 2016, representing more than 200 percent of net income from continuing operations.
Since the beginning of the current $10 billion share repurchase program, the Company repurchased 106.0 million common shares at an average price of $70.51, for a total investment of approximately $7.5 billion.
For the trailing twelve months through first quarter 2016, after-tax return on invested capital (ROIC) was 16.0 percent, compared with 12.5 percent for the twelve months through first quarter 2015. Excluding the net gain on the sale of the pharmacy and clinic businesses, ROIC for the trailing twelve months through first quarter 2016 was 14.0 percent, reflecting higher profits on a stable base of invested capital. See the “Reconciliation of Non-GAAP Financial Measures” section of this release for additional information about the Company’s ROIC calculation.
Discontinued Operations
First quarter net earnings from discontinued operations were $18 million, compared with after-tax losses of ($16) million last year. First quarter 2016 net earnings from discontinued operations primarily reflect foreign currency gains on the Company’s net assets.
Certain assets and liabilities of Target’s discontinued operations are based on estimates. The recorded assets include estimated receivables, and the remaining liabilities include accruals for estimated losses related to claims that may be asserted against Target Corporation, primarily under guarantees of certain leases. These estimates involve significant judgment and are based on currently available information, an assessment of the validity of certain claims and estimated payments by the Canada Subsidiaries. These estimates are subject to change, and the Company believes it is reasonably possible that adjustments to these amounts could be material to its results of operations in future periods. Any such adjustments would be recorded in discontinued operations.
Conference Call Details
Target will webcast its first quarter earnings conference call at 9:30 a.m. CDT today. Investors and the media are invited to listen to the call at Target.com/Investors (hover over “company” then click on “events & presentations” in the “investors” column). A telephone replay of the call will be available beginning at approximately 11:30 a.m. CDT today through the end of business on May 20, 2016. The replay number is (855) 859-2056 (passcode: 56082202).
Miscellaneous
Statements in this release regarding second quarter and full-year 2016 earnings per share guidance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties which could cause the Company’s actual results to differ materially. The most important risks and uncertainties are described in Item 1A of the Company’s Form 10-K for the fiscal year ended Jan. 30, 2016. Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update any forward-looking statement.
In addition to the GAAP results provided in this release, the Company provides Adjusted EPS for the three-month periods ended Apr. 30, 2016, and May 2, 2015. The Company also provides ROIC for the twelve-month periods ended Apr. 30, 2016, and May 2, 2015, respectively, which is a ratio based on GAAP information, with the exception of adjustments made to capitalize operating leases. Operating leases are capitalized as part of the ROIC calculation to control for differences in capital structure between the Company and its competitors. Adjusted EPS, capitalized operating lease obligations and operating lease interest are not in accordance with, or an alternative for, generally accepted accounting principles in the United States. Management believes Adjusted EPS is useful in providing period-to-period comparisons of the results of the Company’s ongoing retail operations. Management believes ROIC is useful in assessing the effectiveness of its capital allocation over time. The most comparable GAAP measure for adjusted diluted EPS is diluted EPS from continuing operations. The most comparable GAAP measure for capitalized operating lease obligations and operating lease interest is total rent expense. Adjusted EPS, capitalized operating lease obligations and operating lease interest should not be considered in isolation or as a substitution for analysis of the Company’s results as reported under GAAP. Other companies may calculate Adjusted EPS and ROIC differently than the Company does, limiting the usefulness of the measure for comparisons with other companies.
About Target
Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,793 stores and at Target.com. Since 1946, Target has given 5 percent of its profit to communities, which today equals more than $4 million a week. For more information, visit Target.com/Pressroom. For a behind-the-scenes look at Target, visit Target.com/abullseyeview or follow @TargetNews on Twitter.
TARGET CORPORATION |
|||||||||||
Consolidated Statements of Operations |
|||||||||||
Three Months Ended | |||||||||||
April 30, | May 2, | ||||||||||
(millions, except per share data) (unaudited) | 2016 | 2015 | Change | ||||||||
Sales | $ | 16,196 | $ | 17,119 | (5.4 | )% | |||||
Cost of sales | 11,185 | 11,911 | (6.1 | ) | |||||||
Gross margin | 5,011 | 5,208 | (3.8 | ) | |||||||
Selling, general and administrative expenses | 3,153 | 3,514 | (10.3 | ) | |||||||
Depreciation and amortization | 546 | 540 | 1.2 | ||||||||
Earnings from continuing operations before interest expense and income taxes | 1,312 | 1,154 | 13.7 | ||||||||
Net interest expense | 415 | 155 | 167.1 | ||||||||
Earnings from continuing operations before income taxes | 897 | 999 | (10.2 | ) | |||||||
Provision for income taxes | 283 | 348 | (18.4 | ) | |||||||
Net earnings from continuing operations | 614 | 651 | (5.8 | ) | |||||||
Discontinued operations, net of tax | 18 | (16 | ) | ||||||||
Net earnings | $ | 632 | $ | 635 | (0.4 | )% | |||||
Basic earnings/(loss) per share | |||||||||||
Continuing operations | $ | 1.03 | $ | 1.02 | 0.9 | % | |||||
Discontinued operations | 0.03 | (0.03 | ) | ||||||||
Net earnings per share | $ | 1.06 | $ | 0.99 | 6.7 | % | |||||
Diluted earnings/(loss) per share | |||||||||||
Continuing operations | $ | 1.02 | $ | 1.01 | 0.9 | % | |||||
Discontinued operations | 0.03 | (0.03 | ) | ||||||||
Net earnings per share | $ | 1.05 | $ | 0.98 | 6.6 | % | |||||
Weighted average common shares outstanding | |||||||||||
Basic | 598.3 | 640.9 | (6.6 | )% | |||||||
Dilutive impact of share-based awards | 5.5 | 5.5 |
|
||||||||
Diluted | 603.8 | 646.4 | (6.6 | )% | |||||||
Antidilutive shares | — | — | |||||||||
Note: Per share amounts may not foot due to rounding.
Subject to reclassification
TARGET CORPORATION |
||||||||||||
Consolidated Statements of Financial Position |
||||||||||||
April 30, | January 30, | May 2, | ||||||||||
(millions) | 2016 | 2016 | 2015 | |||||||||
(unaudited) | (unaudited) | |||||||||||
Assets | ||||||||||||
Cash and cash equivalents, including short term investments of $2,931, $3,008 and $2,073 | $ | 4,036 | $ | 4,046 | $ | 2,768 | ||||||
Inventory (a) | 8,459 | 8,601 | 8,108 | |||||||||
Assets of discontinued operations | 354 | 322 | 143 | |||||||||
Other current assets (a) | 1,099 | 1,161 | 2,037 | |||||||||
Total current assets | 13,948 | 14,130 | 13,056 | |||||||||
Property and equipment | ||||||||||||
Land | 6,120 | 6,125 | 6,135 | |||||||||
Buildings and improvements | 27,198 | 27,059 | 26,636 | |||||||||
Fixtures and equipment | 5,112 | 5,347 | 5,004 | |||||||||
Computer hardware and software | 2,437 | 2,617 | 2,394 | |||||||||
Construction-in-progress | 242 | 315 | 576 | |||||||||
Accumulated depreciation | (16,060 | ) | (16,246 | ) | (14,966 | ) | ||||||
Property and equipment, net | 25,049 | 25,217 | 25,779 | |||||||||
Noncurrent assets of discontinued operations | 81 | 75 | 464 | |||||||||
Other noncurrent assets | 830 | 840 | 969 | |||||||||
Total assets | $ | 39,908 | $ | 40,262 | $ | 40,268 | ||||||
Liabilities and shareholders’ investment | ||||||||||||
Accounts payable | $ | 6,391 | $ | 7,418 | $ | 6,799 | ||||||
Accrued and other current liabilities | 3,833 | 4,236 | 3,674 | |||||||||
Current portion of long-term debt and other borrowings | 1,627 | 815 | 112 | |||||||||
Liabilities of discontinued operations | 168 | 153 | 64 | |||||||||
Total current liabilities | 12,019 | 12,622 | 10,649 | |||||||||
Long-term debt and other borrowings | 12,596 | 11,945 | 12,585 | |||||||||
Deferred income taxes | 841 | 823 | 1,249 | |||||||||
Noncurrent liabilities of discontinued operations | 18 | 18 | 207 | |||||||||
Other noncurrent liabilities | 1,889 | 1,897 | 1,404 | |||||||||
Total noncurrent liabilities | 15,344 | 14,683 | 15,445 | |||||||||
Shareholders’ investment | ||||||||||||
Common stock | 49 | 50 | 53 | |||||||||
Additional paid-in capital | 5,520 | 5,348 | 5,170 | |||||||||
Retained earnings | 7,593 | 8,188 | 9,441 | |||||||||
Accumulated other comprehensive loss | ||||||||||||
Pension and other benefit liabilities | (581 | ) | (588 | ) | (452 | ) | ||||||
Currency translation adjustment and cash flow hedges | (36 | ) | (41 | ) | (38 | ) | ||||||
Total shareholders’ investment | 12,545 | 12,957 | 14,174 | |||||||||
Total liabilities and shareholders’ investment | $ | 39,908 | $ | 40,262 | $ | 40,268 |
Common Stock Authorized 6,000,000,000 shares, $.0833 par value; 593,583,619, 602,226,517 and 638,408,643 shares issued and outstanding at April 30, 2016, January 30, 2016 and May 2, 2015, respectively.
Preferred Stock Authorized 5,000,000 shares, $.01 par value; no shares were issued or outstanding at April 30, 2016, January 30, 2016 or May 2, 2015.
(a) At May 2, 2015, $502 million of pharmacy prescription inventory was included in other current assets.
Subject to reclassification
TARGET CORPORATION |
||||||||
Consolidated Statements of Cash Flows |
||||||||
Three Months Ended | ||||||||
April 30, | May 2, | |||||||
(millions) (unaudited) | 2016 | 2015 | ||||||
Operating activities | ||||||||
Net earnings | $ | 632 | $ | 635 | ||||
Earnings / (losses) from discontinued operations, net of tax | 18 | (16 | ) | |||||
Net earnings from continuing operations | 614 | 651 | ||||||
Adjustments to reconcile net earnings to cash provided by operations: | ||||||||
Depreciation and amortization | 546 | 540 | ||||||
Share-based compensation expense | 35 | 26 | ||||||
Deferred income taxes | 12 | 18 | ||||||
Loss on debt extinguishment | 261 | — | ||||||
Noncash (gains) / losses and other, net |
(24 |
) | (19 | ) | ||||
Changes in operating accounts: | ||||||||
Inventory | 142 | 180 | ||||||
Other assets | 107 | 138 | ||||||
Accounts payable and accrued liabilities | (1,440 | ) | (757 | ) | ||||
Cash provided by operating activities—continuing operations |
253 |
777 | ||||||
Cash (required for) / provided by operating activities—discontinued operations | (6 | ) | 834 | |||||
Cash provided by operations |
247 |
1,611 | ||||||
Investing activities | ||||||||
Expenditures for property and equipment | (285 | ) | (352 | ) | ||||
Proceeds from disposal of property and equipment | 3 | 6 | ||||||
Other investments | 3 | 21 | ||||||
Cash required for investing activities—continuing operations | (279 | ) | (325 | ) | ||||
Cash provided by investing activities—discontinued operations | — | 19 | ||||||
Cash required for investing activities | (279 | ) | (306 | ) | ||||
Financing activities | ||||||||
Additions to long-term debt | 1,979 | — | ||||||
Reductions of long-term debt |
(863 |
) | (14 | ) | ||||
Dividends paid | (336 | ) | (333 | ) | ||||
Repurchase of stock | (898 | ) | (486 | ) | ||||
Prepayment of accelerated share repurchase | — | (120 | ) | |||||
Stock option exercises | 140 | 206 | ||||||
Cash provided by / (required for) financing activities |
22 |
(747 | ) | |||||
Effect of exchange rate changes on cash and cash equivalents | — | — | ||||||
Net (decrease) / increase in cash and cash equivalents | (10 | ) | 558 | |||||
Cash and cash equivalents at beginning of period | 4,046 | 2,210 | ||||||
Cash and cash equivalents at end of period | $ | 4,036 | $ | 2,768 | ||||
Subject to reclassification
TARGET CORPORATION |
|||||||||||
Segment Results |
|||||||||||
Three Months Ended | |||||||||||
April 30, | May 2, | ||||||||||
(millions) (unaudited) | 2016 |
2015 (a) |
Change | ||||||||
Sales | $ | 16,196 | $ | 17,119 | (5.4 | )% | |||||
Cost of sales | 11,185 | 11,911 | (6.1 | ) | |||||||
Gross margin | 5,011 | 5,208 | (3.8 | ) | |||||||
SG&A expenses (b) | 3,142 | 3,407 | (7.8 | ) | |||||||
EBITDA | 1,869 | 1,801 | 3.8 | ||||||||
Depreciation and amortization | 546 | 540 | 1.2 | ||||||||
EBIT | $ | 1,323 | $ | 1,261 | 4.9 |
% |
|||||
Note: We operate as a single segment which includes all of our continuing operations, excluding net interest expense and certain other expenses that are discretely managed. Our segment operations are designed to enable guests to purchase products seamlessly in stores, online, or through mobile devices. |
|||||||||||
(a) Sales and cost of sales include $1,075 million and $862 million, respectively, related to our former pharmacy and clinic businesses. The December 2015 sale of these businesses to CVS had no notable impact on EBITDA or EBIT. The impact of the perpetual operating agreement entered into with CVS at the close of the transaction, as described in our Form 10-K for the fiscal year ended January 30, 2016, is not expected to be material to any individual period. |
|||||||||||
(b) For the three months ended April 30, 2016 and May 2, 2015, SG&A includes $158 million and $152 million, respectively, of net profit-sharing income under our credit card program agreement. |
|||||||||||
Three Months Ended | ||||||
Segment Rate Analysis | April 30, | May 2, | ||||
(unaudited) | 2016 | 2015 | ||||
Gross margin rate | 30.9 | % | 30.4 | % | ||
SG&A expense rate | 19.4 | 19.9 | ||||
EBITDA margin rate (a) | 11.5 | 10.5 | ||||
Depreciation and amortization expense rate | 3.4 | 3.2 | ||||
EBIT margin rate (a) | 8.2 | 7.4 | ||||
Note: Rate analysis metrics are computed by dividing the applicable amount by sales. |
||||||
(a) Excluding sales of our former pharmacy and clinic businesses, EBITDA and EBIT margin rates were 11.2 percent and 7.9 percent, respectively, for the three months ended May 2, 2015. |
||||||
|
||||||
Three Months Ended | ||||||
Sales by Channel | April 30, | May 2, | ||||
(unaudited) | 2016 | 2015 ((a)) | ||||
Stores | 96.5 | % | 97.2 | % | ||
Digital | 3.5 | 2.8 | ||||
Total | 100 | % | 100 | % | ||
(a) Excluding sales of our former pharmacy and clinic businesses, stores and digital channels sales were 97.0 percent and 3.0 percent of total sales, respectively, for the three months ended May 2, 2015. |
||||||
Three Months Ended | ||||||
Comparable Sales | April 30, | May 2, | ||||
(unaudited) | 2016 | 2015 | ||||
Comparable sales change | 1.2 | % | 2.3 | % | ||
Drivers of change in comparable sales | ||||||
Number of transactions | 0.3 | 0.9 | ||||
Average transaction amount | 0.9 | 1.4 | ||||
Selling price per unit | 2.9 | 5.1 | ||||
Units per transaction | (2.0 | ) | (3.6 | ) | ||
Note: Amounts may not foot due to rounding. |
||||||
|
||||||
Contribution to Comparable Sales Change |
Three Months Ended | |||||
April 30, |
May 2, |
|||||
Stores channel comparable sales change | 0.6 | % | 1.5 | % | ||
Digital channel contribution to comparable sales change | 0.6 | 0.8 | ||||
Total comparable sales change | 1.2 | % | 2.3 | % | ||
Note: Amounts may not foot due to rounding. |
||||||
|
||||||
Three Months Ended | ||||||
REDcard Penetration |
April 30, |
May 2, |
||||
Target Debit Card | 13.0 | % | 12.0 | % | ||
Target Credit Cards | 10.4 | 9.4 | ||||
Total REDcard Penetration | 23.4 | % | 21.5 | % | ||
Note: Amounts may not foot due to rounding. |
||||||
(a) Excluding pharmacy and clinic sales, total REDcard penetration would have been 22.6 percent for the three months ended May 2, 2015. |
||||||
Number of Stores and Retail Square Feet |
Number of Stores | Retail Square Feet (a) | |||||||||||||||
April 30, |
January 30, |
May 2, |
April 30, |
January 30, |
May 2, |
||||||||||||
170,000 or more sq. ft. | 278 | 278 | 280 | 49,688 | 49,688 | 50,036 | |||||||||||
50,000 to 169,999 sq. ft. |
1,505 | 1,505 | 1,512 | 189,677 | 189,677 | 190,316 | |||||||||||
49,999 or less sq. ft. | 10 | 9 | 3 | 211 | 174 | 62 | |||||||||||
Total | 1,793 | 1,792 | 1,795 | 239,576 | 239,539 | 240,414 |
(a) In thousands: reflects total square feet, less office, distribution center and vacant space.
Subject to reclassification
TARGET CORPORATION
Reconciliation of Non-GAAP Financial Measures
To provide additional transparency, we have disclosed non-GAAP adjusted diluted earnings per share from continuing operations (Adjusted EPS). This metric excludes certain costs presented below. We believe this information is useful in providing period-to-period comparisons of the results of our continuing operations. This measure is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. The most comparable GAAP measure is diluted earnings per share from continuing operations. Adjusted EPS should not be considered in isolation or as a substitution for analysis of our results as reported under GAAP. Other companies may calculate Adjusted EPS differently than we do, limiting the usefulness of the measure for comparisons with other companies.
Adjusted EPS | Three Months Ended | ||||||||||||||||||||||
April 30, 2016 | May 2, 2015 | ||||||||||||||||||||||
Net of | Per Share | Net of | Per Share | ||||||||||||||||||||
(millions, except per share data) (unaudited) | Pretax | Tax | Amounts | Pretax | Tax | Amounts | Change | ||||||||||||||||
GAAP diluted earnings per share from continuing operations |
$ | 1.02 | $ | 1.01 | 0.9 | % | |||||||||||||||||
Adjustments | |||||||||||||||||||||||
Loss on early retirement of debt | $ | 261 | $ | 159 | $ | 0.26 | $ | — | $ | — | $ | — | |||||||||||
Restructuring costs (a) | — | — | — | 103 | 64 | 0.10 | |||||||||||||||||
Other (b) | 11 | 7 | 0.01 | 3 | 2 | — | |||||||||||||||||
Resolution of income tax matters | — | (2 | ) | — | — |
(3 |
) | — | |||||||||||||||
Adjusted diluted earnings per share from continuing operations | $ | 1.29 | $ | 1.10 | 16.5 | % |
Note: Amounts may not foot due to rounding.
(a)
Costs related to our corporate restructuring announced during the first
quarter of 2015.
(b) For the three months ended
April 30, 2016, represents contract termination charges, severance and
other costs related to the December 2015 sale of our former pharmacy and
clinic businesses to CVS. For the three months ended May 2, 2015,
represents costs related to the 2013 data breach.
We have also disclosed after-tax return on invested capital for continuing operations (ROIC), which is a ratio based on GAAP information, with the exception of adjustments made to capitalize operating leases. Operating leases are capitalized as part of the ROIC calculation to control for differences in capital structure between us and our competitors. We believe this metric provides a meaningful measure of the effectiveness of our capital allocation over time. Other companies may calculate ROIC differently than we do, limiting the usefulness of the measure for comparisons with other companies.
After-Tax Return on Invested Capital | |||||||||||
Numerator | Trailing Twelve Months | ||||||||||
April 30, | May 2, | ||||||||||
(dollars in millions) (unaudited) | 2016 | 2015 | |||||||||
Earnings from continuing operations before interest expense and income taxes | $ | 5,688 | $ | 4,667 | |||||||
+ Operating lease interest (a)(b) | 82 | 90 | |||||||||
Adjusted earnings from continuing operations before interest expense and income taxes | 5,770 | 4,756 | |||||||||
- Income taxes (c) | 1,840 | 1,575 | |||||||||
Net operating profit after taxes | $ | 3,930 | $ | 3,181 | |||||||
Denominator | April 30, | May 2, | May 3, | ||||||||
(dollars in millions) (unaudited) | 2016 | 2015 | 2014 | ||||||||
Current portion of long-term debt and other borrowings | $ | 1,627 | $ | 112 | $ | 1,466 | |||||
+ Noncurrent portion of long-term debt | 12,596 | 12,585 | 11,315 | ||||||||
+ Shareholders' equity | 12,545 | 14,174 | 16,486 | ||||||||
+ Capitalized operating lease obligations (b)(d) | 1,367 | 1,495 | 1,587 | ||||||||
- Cash and cash equivalents | 4,036 | 2,768 | 677 | ||||||||
- Net assets of discontinued operations | 249 | 335 | 4,573 | ||||||||
Invested capital | $ | 23,850 | $ | 25,263 | $ | 25,604 | |||||
Average invested capital (e) | $ | 24,556 | $ | 25,434 | |||||||
After-tax return on invested capital (f) | 16.0 | % | 12.5 | % |
(a) Represents the hypothetical capitalization of our
operating leases, using eight times our trailing twelve months rent
expense and an estimated interest rate of six percent.
(b)
See the following Reconciliation of Capitalized Operating Leases table
for the adjustments to our GAAP total rent expense to obtain the
hypothetical capitalization of operating leases and related operating
lease interest.
(c) Calculated using the
effective tax rate for continuing operations, which was 31.9% and 33.1%
for the trailing twelve months ended April 30, 2016 and May 2, 2015.
(d)
Calculated as eight times our trailing twelve months rent expense.
(e)
Average based on the invested capital at the end of the current period
and the invested capital at the end of the prior period.
(f)
Excluding the net gain on the sale of our pharmacy and clinic
businesses, ROIC was 14.0 percent for the trailing twelve months ended
April 30, 2016.
Capitalized operating lease obligations and operating lease interest are not in accordance with, or an alternative for, generally accepted accounting principles in the United States. The most comparable GAAP measure is total rent expense. Capitalized operating lease obligations and operating lease interest should not be considered in isolation or as a substitution for analysis of our results as reported under GAAP.
Reconciliation of Capitalized Operating Leases | Trailing Twelve Months | ||||||||||
April 30, | May 2, | May 3, | |||||||||
(dollars in millions) (unaudited) | 2016 | 2015 | 2014 | ||||||||
Total rent expense | $ | 171 | $ | 187 | $ | 199 | |||||
Capitalized operating lease obligations (total rent expense x 8) | 1,367 | 1,495 | 1,587 | ||||||||
Operating lease interest (capitalized operating lease obligations x 6%) | 82 | 90 | n/a | ||||||||
Subject to reclassification